Corporate News – Phathom Pharmaceuticals, Inc. (PHAT)
Market Performance
- Last 24‑hour movement: Phathom (PHAT) increased 4.28 % to close at USD 7.12 on 21 Oct 2026.
- Trading volume: Approximately USD 5.3 million of PHAT shares were traded.
- Market capitalization: USD 556.8 million.
- Shares outstanding: 79.4 million.
- 24‑hour trading range: Highest USD 18.31 (23 Dec 2025); lowest USD 6.52 (6 Oct 2026).
- Simple moving average (200 days): USD 10.82.
- Year‑to‑date performance: Down 1.88 % since the end of last month.
Earnings Release Highlights
- Phathom reported a modest upward movement in its share price after a positive earnings release.
- The company emphasized growth in its core therapeutic areas and a strengthened product pipeline, noting progress in late‑stage clinical trials.
- Guidance for the upcoming fiscal year was presented as a solid trajectory, though analysts noted potential short‑term market volatility.
- Management reiterated a focus on expanding global partnerships and maintaining disciplined capital allocation.
- Investor reaction suggested cautious optimism, with concerns about competitive dynamics and regulatory timelines persisting.
Related Stock Activity (24 h)
| Ticker | 24‑h % Move | Current Price (USD) | Market Cap (USD mn) | Notes |
|---|---|---|---|---|
| MSBI (Midland States) | +2.39 % | 32.51 | 659.9 | Filed effective S‑3 registration; no other material disclosures. |
| SABR (Sabre) | –4.27 % | 1.51 | 661.9 | – |
| DSGN (Design Therapeutics) | +4.32 % | 10.71 | 665.9 | – |
| BTGO (Bitgo) | +2.32 % | 6.16 | 659.4 | Subject of a breach‑of‑contract claim; no comment from Bitgo. |
| ANGX (Angel Studios) | –1.98 % | 3.48 | 659.3 | – |
Company Profile
Phathom Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing treatments for gastrointestinal (GI) diseases and disorders. It operates within the health‑care sector and serves both the gastrointestinal and pharmaceutical industries. The company is headquartered in Illinois and is listed on the Nasdaq stock exchange. More information can be found on its website: www.phathompharma.com .
